# A Study to Explore Pharmacodynamic Effects of BIIB104 on Brain Circuitry in Healthy Participants

> **NCT04068532** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 30 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Placebo
- **DRUG:** BIIB104

## Key facts

- **NCT ID:** NCT04068532
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-15
- **Primary completion:** 2020-11-11
- **Final completion:** 2020-11-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04068532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04068532, "A Study to Explore Pharmacodynamic Effects of BIIB104 on Brain Circuitry in Healthy Participants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04068532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*